PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.\', \'Department of Medicine, Boston University School of Medicine, Boston, MA, USA.\', \'Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Global Health, Boston University School of Public Health, Boston, MA, USA.\', \'Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; National Emerging Infectious Disease Laboratory, Boston, MA, USA.\', \'Pulmonary Center, Boston University School of Medicine, Boston, MA, USA.\', \'Section of Pediatric Infectious Diseases, Boston Medical Center, Boston, MA, USA.\', \'Department of Pharmacy, Boston Medical Center, Boston, MA, USA.\', \'Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.\', \'Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA. Electronic address: msagar@bu.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(20)30568-310.1016/j.ijid.2020.07.023
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 32721528
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all